Tag Archives: SAH

Hot Blue Chip Stocks To Watch Right Now

Shutterstock

Fact: When interest rates rise, you need to be in dividend-growth stocks.

Proof: They’ve handily beaten the S&P 500 in the 17 months since the Federal Reserve put the zero-interest-rate era on ice.

In just a moment, I’ll show you 2 terrific off-the-radar dividend-growth plays to snap up now—and 2 surprising blue chips you’ll want to keep well away from your nest egg.

First, take a look at how the iShares Core Dividend-Growth ETF (DGRO) has performed vs. the SPDR S&P 500 ETF (SPY) on a total-return basis since December 16, 2015, the day Janet Yellen raised rates for the first time in nine years.

The Dividend-Growth Edge in 1 Chart

Hot Blue Chip Stocks To Watch Right Now: Beneficial Mutual Bancorp Inc.(BNCL)

Advisors’ Opinion:

  • [By Joseph Griffin]

    Beneficial Bancorp Inc (NASDAQ:BNCL) Director Thomas J. Lewis sold 973 shares of the company’s stock in a transaction dated Wednesday, May 30th. The stock was sold at an average price of $16.50, for a total value of $16,054.50. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website.

  • [By Logan Wallace]

    Beneficial Bancorp (NASDAQ: BNCL) and Home Bancorp (NASDAQ:HBCP) are both small-cap finance companies, but which is the superior stock? We will compare the two businesses based on the strength of their profitability, earnings, institutional ownership, analyst recommendations, risk, dividends and valuation.

  • [By Ethan Ryder]

    BidaskClub upgraded shares of Beneficial Bancorp (NASDAQ:BNCL) from a sell rating to a hold rating in a report released on Tuesday morning.

    Shares of Beneficial Bancorp opened at $16.35 on Tuesday, MarketBeat.com reports. The company has a quick ratio of 1.09, a current ratio of 1.09 and a debt-to-equity ratio of 0.51. The company has a market capitalization of $1.23 billion, a P/E ratio of 31.44 and a beta of 0.55. Beneficial Bancorp has a fifty-two week low of $14.40 and a fifty-two week high of $17.50.

  • [By Joseph Griffin]

    Media coverage about Beneficial Bancorp (NASDAQ:BNCL) has trended positive recently, according to Accern. Accern identifies positive and negative news coverage by monitoring more than twenty million news and blog sources in real-time. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores closest to one being the most favorable. Beneficial Bancorp earned a news impact score of 0.38 on Accern’s scale. Accern also gave media headlines about the bank an impact score of 45.8699493506664 out of 100, meaning that recent news coverage is somewhat unlikely to have an effect on the stock’s share price in the next several days.

Hot Blue Chip Stocks To Watch Right Now: Advance Auto Parts Inc(AAP)

Advisors’ Opinion:

  • [By Joseph Griffin]

    Advance Auto Parts (NYSE:AAP) – Equities researchers at Wedbush issued their Q1 2019 earnings per share (EPS) estimates for Advance Auto Parts in a research report issued on Tuesday, May 15th. Wedbush analyst S. Basham expects that the company will post earnings per share of $2.31 for the quarter. Wedbush has a “Buy” rating and a $130.00 price objective on the stock. Wedbush also issued estimates for Advance Auto Parts’ Q2 2019 earnings at $2.20 EPS, Q3 2019 earnings at $2.02 EPS and Q4 2019 earnings at $1.42 EPS.

  • [By Chris Lange]

    Advance Auto Parts Inc. (NYSE: AAP) and AutoZone Inc. (NYSE: AZO) each saw shares make a handy gain early on Tuesday. These companies have reported their most recent quarterly results, and while each had somewhat mixed reports, the overall outcome was good enough to give the shares a nice bump.

  • [By Lisa Levin] Companies Reporting Before The Bell
    Advance Auto Parts, Inc. (NYSE: AAP) is projected to report quarterly earnings at $1.97 per share on revenue of $2.91 billion.
    Kohl's Corporation (NYSE: KSS) is expected to report quarterly earnings at $0.5 per share on revenue of $3.95 billion.
    The TJX Companies, Inc. (NYSE: TJX) is projected to report quarterly earnings at $1.02 per share on revenue of $8.47 billion.
    AutoZone, Inc. (NYSE: AZO) is estimated to report quarterly earnings at $13.01 per share on revenue of $2.72 billion.
    Dycom Industries, Inc. (NYSE: DY) is projected to report quarterly earnings at $0.7 per share on revenue of $734.86 million.
    Eaton Vance Corp. (NYSE: EV) is estimated to report quarterly earnings at $0.79 per share on revenue of $425.42 million.
    Photronics, Inc. (NASDAQ: PLAB) is expected to report quarterly earnings at $0.07 per share on revenue of $124.17 million.
    Cracker Barrel Old Country Store, Inc. (NASDAQ: CBRL) is estimated to report quarterly earnings at $1.93 per share on revenue of $715.15 million.
    Radcom Ltd. (NASDAQ: RDCM) is expected to post quarterly earnings at $1.96 per share on revenue of $718.59 million.
    Clear Channel Outdoor Holdings, Inc. (NYSE: CCO) is projected to report quarterly earnings at $0.04 per share on revenue of $718.96 million.
    CYREN Ltd. (NASDAQ: CYRN) is estimated to report quarterly loss at $0.08 per share on revenue of $7.72 million.
    Ferroglobe PLC (NYSE: GSM) is projected to report quarterly earnings at $0.16 per share on revenue of $559.15 million.
    Dr. Reddy's Laboratories Limited (NYSE: RDY) is estimated to report earnings for its fourth quarter.
    BioLineRx Ltd. (NASDAQ: BLRX) is expected to report quarterly loss at $0.07 per share.
    Toll Brothers, Inc. (NYSE: TOL) is estimated to post quarterly earnings at $0.76 per share on revenue of $1.58 billion.

     

  • [By Taylor Cox]

    Tuesday
    Notable Earnings

    Advance Auto Parts, Inc (NYSE: AAP) Q1 premarket
    AutoZone, Inc (NYSE: AZO) Q3 premarket
    Kohl’s Corporation (NYSE: KSS) Q1 premarket
    The TJX Companies, Inc (NYSE: TJX) Q1 premarket
    Hewlett Packard Enterprise Company (NYSE: HPE) Q2 after hours
    Intuit Inc (NASDAQ: INTU) Q3 after hours
    Urban Outfitters, Inc (NASDAQ: URBN) Q1 after hours

    IPOs

Hot Blue Chip Stocks To Watch Right Now: S&P GSCI(GD)

Advisors’ Opinion:

  • [By Logan Wallace]

    Get a free copy of the Zacks research report on General Dynamics (GD)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By ]

    Moreno was also upbeat on General Dynamics (GD) , which just made a bullish crossover, but felt that Raytheon had the best chart of them all.

    Cramer agreed, saying he’s bullish on all of these names.

  • [By Lisa Levin] Companies Reporting Before The Bell
    Thermo Fisher Scientific Inc. (NYSE: TMO) is projected to report quarterly earnings at $2.4 per share on revenue of $5.63 billion.
    Ford Motor Company (NYSE: F) is expected to report quarterly earnings at $0.41 per share on revenue of $37.16 billion.
    Twitter, Inc. (NYSE: TWTR) is projected to report quarterly earnings at $0.11 per share on revenue of $605.26 million.
    Comcast Corporation (NASDAQ: CMCSA) is expected to report quarterly earnings at $0.59 per share on revenue of $22.75 billion.
    General Dynamics Corporation (NYSE: GD) is estimated to report quarterly earnings at $2.52 per share on revenue of $7.6 billion.
    The Boeing Company (NYSE: BA) is expected to report quarterly earnings at $2.58 per share on revenue of $22.24 billion.
    Anthem, Inc. (NYSE: ANTM) is estimated to report quarterly earnings at $4.91 per share on revenue of $22.52 billion.
    Viacom, Inc. (NASDAQ: VIAB) is projected to report quarterly earnings at $0.79 per share on revenue of $3.04 billion.
    Northrop Grumman Corporation (NYSE: NOC) is estimated to report quarterly earnings at $3.61 per share on revenue of $6.61 billion.
    Rockwell Automation Inc. (NYSE: ROK) is expected to report quarterly earnings at $1.81 per share on revenue of $1.66 billion.
    Wipro Limited (NYSE: WIT) is projected to report quarterly earnings at $0.07 per share on revenue of $2.15 billion.
    The Goodyear Tire & Rubber Company (NASDAQ: GT) is expected to report quarterly earnings at $0.46 per share on revenue of $3.82 billion.
    Owens Corning (NYSE: OC) is projected to report quarterly earnings at $0.97 per share on revenue of $1.62 billion.
    T. Rowe Price Group, Inc. (NASDAQ: TROW) is estimated to report quarterly earnings at $1.71 per share on revenue of $1.29 billion.
    Dr Pepper Snapple Group, Inc. (NYSE: DPS) is expected to report quarterly earnings at $1.04 per share on revenue of $1.57 billion.
    Sirius XM Holdings Inc. (NASDAQ: SI
  • [By Joseph Griffin]

    Riverhead Capital Management LLC increased its holdings in shares of General Dynamics (NYSE:GD) by 223.5% in the 1st quarter, according to its most recent filing with the SEC. The fund owned 12,055 shares of the aerospace company’s stock after purchasing an additional 8,328 shares during the period. Riverhead Capital Management LLC’s holdings in General Dynamics were worth $2,663,000 at the end of the most recent reporting period.

  • [By Lou Whiteman]

    The deal, in effect, makes General Dynamics-owned (NYSE:GD) Gulfstream both a customer of and subcontractor to Triumph on G650 wing box and wing completion work. Wing production work currently being performed at Triumph facilities in Nashville, Tennessee, and Tulsa, Oklahoma, will move to Gulfstream’s Georgia facility.

  • [By ]

    Only 10% of the companies on the list had female CEOs at the helm, four of which — Hewlett Packard (HP) , Lockheed Martin (LMT) , General Motors (GM) , and General Dynamics (GD) — grew significant revenue in five years or less. 

Hot Blue Chip Stocks To Watch Right Now: Urban Outfitters Inc.(URBN)

Advisors’ Opinion:

  • [By Lisa Levin]

    Some of the stocks that may grab investor focus today are:

    Wall Street expects Lowe's Companies, Inc. (NYSE: LOW) to report quarterly earnings at $1.25 per share on revenue of $17.63 billion before the opening bell. Lowe's shares declined 0.35 percent to $85.45 in pre-market trading.
    Analysts expect NetApp, Inc. (NASDAQ: NTAP) to post quarterly earnings at $1.01 per share on revenue of $1.60 billion after the closing bell. NetApp shares dropped 2.09 percent to close at $67.02 on Tuesday.
    Urban Outfitters, Inc. (NASDAQ: URBN) reported better-than-expected earnings for its fiscal first quarter on Tuesday. Urban Outfitters shares dropped 2.21 percent to $40.30 in the pre-market trading session.
    Before the markets open, Tiffany & Co. (NYSE: TIF) is projected to report quarterly earnings at $0.83 per share on revenue of $957.49 million. Tiffany shares gained 0.45 percent to $102.70 in pre-market trading.
    Analysts are expecting Target Corporation (NYSE: TGT) to have earned $1.38 per share on revenue of $16.50 billion in the latest quarter. Target will release earnings before the markets open. Target shares rose 0.07 percent to $75.52 in pre-market trading.
    Hewlett Packard Enterprise Co (NYSE: HPE) reported stronger-than-expected profit for its fiscal second quarter and raised its FY18 GAAP earnings outlook. Hewlett Packard Enterprise shares rose 0.40 percent to $17.48 in pre-market trading.

    Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.

  • [By ]

    In the mid-level, Boss said that Urban Outfitters (URBN) is recovering, along with Kohl’s Stores (KSS) . He also liked PVH (PVH) and Lululemon Athletica (LULU) .

  • [By Chris Lange]

    Urban Outfitters Inc. (NASDAQ: URBN) is scheduled to release its most recent quarterly results after the markets close on Tuesday. The consensus estimates from Thomson Reuters call for $0.63 in earnings per share (EPS) on $1.08 billion in revenue. In the fourth quarter of last year, the retailer said it had EPS of $0.55 and $1.03 billion in revenue.

  • [By Shane Hupp]

    Get a free copy of the Zacks research report on Urban Outfitters (URBN)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Logan Wallace]

    Investors sold shares of Urban Outfitters (NASDAQ:URBN) on strength during trading on Thursday. $17.36 million flowed into the stock on the tick-up and $38.83 million flowed out of the stock on the tick-down, for a money net flow of $21.47 million out of the stock. Of all equities tracked, Urban Outfitters had the 26th highest net out-flow for the day. Urban Outfitters traded up $0.44 for the day and closed at $42.76

  • [By Shane Hupp]

    Urban Outfitters (NASDAQ: URBN) and TJX Companies (NYSE:TJX) are both retail/wholesale companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, risk, dividends, valuation, analyst recommendations, profitability and earnings.

Hot Blue Chip Stocks To Watch Right Now: Sonic Automotive Inc.(SAH)

Advisors’ Opinion:

  • [By Jon C. Ogg]

    Sonic Automotive Inc. (NYSE: SAH) was downgraded to Underweight from Overweight, and the price target was cut to $19 from $25. The shares were at $21.70 ahead of the call and were trading down 4.6% at $20.70 Tuesday morning. The 52-week range is $15.95 to $23.60. The consensus target price was $21.83.

  • [By Ethan Ryder]

    These are some of the media stories that may have effected Accern’s scoring:

    Get Sonic Automotive alerts:

    Sonic Automotive (SAH) Given “Hold” Rating at Stephens (americanbankingnews.com) Equities Analysts Issue Forecasts for Sonic Automotive Inc’s Q2 2018 Earnings (SAH) (americanbankingnews.com) Auto Stock Roundup: Tariff Woes Rampant, Ford to Settle Takata Lawsuit (finance.yahoo.com) Q3 2018 EPS Estimates for Sonic Automotive Inc (SAH) Reduced by Analyst (americanbankingnews.com) Sonic Automotive (SAH) Issues Warning on Q2 Earnings (streetinsider.com)

    A number of brokerages have recently issued reports on SAH. Zacks Investment Research lowered Sonic Automotive from a “buy” rating to a “hold” rating in a research report on Thursday. Stephens reiterated a “hold” rating and set a $18.00 target price on shares of Sonic Automotive in a research report on Friday. ValuEngine lowered Sonic Automotive from a “hold” rating to a “sell” rating in a research report on Thursday. Buckingham Research decreased their target price on Sonic Automotive from $21.00 to $19.00 and set a “$19.55” rating on the stock in a research report on Wednesday. Finally, Morgan Stanley lowered Sonic Automotive from an “overweight” rating to an “underweight” rating and set a $25.00 target price on the stock. in a research report on Tuesday, July 10th. Three research analysts have rated the stock with a sell rating and four have issued a hold rating to the stock. The company has a consensus rating of “Hold” and an average price target of $21.60.

Top Safest Stocks To Own For 2019

Go back a year, and offshore drillers like Noble (NE), Rowan (RDC), Transocean (RIG) and Atwood Oceanics (ATW) had been all but written off–until they weren’t anymore. Since then, investors have been rewarded for picking winners in the group from the losers, as Atwood Oceanics has more than doubled, Transocean has gained 34%, and Rowan has risen 42%, while Noble and Diamond Offshore Drilling (DO) have dropped 13%.

Agence France-Presse/Getty Images

But are the days of picking stocks among offshore drillers over? Consider: Today, Jefferies analyst Eduardo Royes and team upgraded Noble to Buy and cut Rowan to Hold, clearly favoring one over the other. They explain why:

Given where we sit in the cycle, we cannot favorably recommend the group. That said, we can still see relative value (or lack thereof) in shares. We upgrade Noble to Buy as we view it as the ‘safest’ way to play offshore drilling exposure at the moment we see modest upside to shares on a DCF and relative valuation basis. Meanwhile we downgrade Rowan to Hold as despite still generating healthy free cash flow, we see risk that medium-term earnings disappoint (we’re >30% below ’18 Street EBITDA) as the ‘turn’ in jackups and ultra-deep-water markets is likely challenged from a profitability standpoint. Outside of Rowan and Noble, we skew favorably to Hold-rated Ensco (ESV) and Transocean.

Top Safest Stocks To Own For 2019: Atwood Oceanics, Inc.(ATW)

Advisors’ Opinion:

  • [By Jason Hall]

    April was another bad month for offshore drilling stocks. Transocean Ltd. (NYSE:RIG), ENSCO Plc. (NYSE:ESV), Diamond Offshore Drilling Inc. (NYSE:DO), Atwood Oceanic Inc.(NYSE:ATW), and Noble Corporation (NYSE:NE) all held up relatively well through the first third of the month, but then start to fall around April 10.

  • [By Benzinga News Desk]

    Stephens (Equal-Weight) and Citi (Sell) both downgraded Atwood Oceanics (NYSE: ATW).

    Sell-Side's Most Noteworthy Calls
    Investec downgraded Anheuser-Busch (NYSE: BUD) to Hold.
    Deutsche Bank downgraded Freeport McMoRan (NYSE: FCX) to Hold.
    Goldman Sachs upgraded Microsoft (NASDAQ: MSFT) to Buy.
    Barclays upgraded Teck Resources (NYSE: TCK) to Overweight.
    BTIG started Adobe (NASDAQ: ADBE) at Neutral.
    Deal Talk

    U.S. oil refiner Tesoro (NYSE: TSO) said it would buy Western Refining (NYSE: WNR) for $4.1 billion to add refineries in Texas, New Mexico and Minnesota. The combined company will have refining capacity of over 1.1 million barrels per day. Tesoro has refineries in California, Washington, Alaska, Utah and North Dakota.

  • [By Lee Jackson]

    Atwood Oceanics Inc. (NYSE: ATW) was reiterated with a Hold rating at Jefferies, but the firm raisedits price target on the shares to $13 from $8. That compares with a Wall Street consensus price objective of $8.90. The 52-week trading range for the stock is $4.82 to $15.87. The stock closed Thursday at $13.55.

  • [By Matthew DiLallo]

    Shares of Atwood Oceanics (NYSE:ATW) are bounding higher on Wednesday and were up more than 13% by 3:00 p.m. EDT. There wasn’t any news to drive the stock higher today. Instead, it appears that investors finally decided they like the company’s messy fiscal second-quarter report.

  • [By Dan Caplinger]

    The stock market climbed Wednesday, with all three major market benchmarks finishing on the plus side. The Dow rose back to within 50 points of the 20,000 mark, and although negative comments from President-elect Donald Trump about drug pricing during his press conference caused poor performance in that sector, the general mood among investors remained positive as earnings season approaches. Also, good news on several fronts helped lift individual stocks, and Kornit Digital (NASDAQ:KRNT), Workday (NYSE:WDAY), and Atwood Oceanics (NYSE:ATW) were among the best performers on the day. Below, we’ll look more closely at these stocks to tell you why they did so well.

  • [By Lisa Levin]

    Energy sector was the top gainer in the US market on Wednesday. Top gainers in the sector included TETRA Technologies, Inc. (NYSE: TTI), CARBO Ceramics Inc. (NYSE: CRR), and Atwood Oceanics, Inc. (NYSE: ATW).

Top Safest Stocks To Own For 2019: Sanofi(SNY)

Advisors’ Opinion:

  • [By William Romov]

    And there’s a dividend stock on this list with an even higher yield…

    Best Dividend Stocks for Retirees No. 1: Sanofi (NYSE: SNY)

    Join the conversation. Click here to jump to comments…

  • [By Cory Renauer]

    Shares ofRegeneron Pharmaceuticals Inc. (NASDAQ:REGN) created a high-water mark around three and a half years ago that’s still 51% above recent prices. The drugs it outlicensed to its big pharma partner,Sanofi(NYSE:SNY), succeeded in the clinic. Unfortunately, commercial launches that take baby steps when investors expect giant leaps can pressure even a biotech’s stock price no matter how productive its discovery engine may be.

  • [By Todd Campbell]

    Biogen’s suite of MS drugs makes it the biggest maker of multiple sclerosis drugs, by market share, but Teva Pharmaceutical, Novartis (NYSE:NVS), and Sanofi SA (NYSE:SNY) are also racking up billions in sales annually in the indication.

  • [By Money Morning Staff Reports]

    The drug is currently in phase 1 of an extensive trial, after which the U.S. Department of Health and Human Services (DHHS) will pass the vaccine on to French pharmaceutical company Sanofi SA (NYSE ADR: SNY). Sanofi will carry out the vaccine’s phase 2 and phase 3 trials because “of the high risk and high costs involved in advanced vaccine development,” the Army wrote in an April 21 public letter on its website.

  • [By ]

    While vaccines are not thought to be as effective this year, the severity of the season could drive higher volume for drug makers. Experts have said the AstraZeneca (NYSE: AZN) vaccine FluMist may not be effective against this year’s strain of flu and are instead recommending the Sanofi (NYSE: SNY) FluZone vaccine. GlaxoSmithKline (NYSE: GSK) has recently been approved for use of its FluLaval vaccine in children as young as six months.

Top Safest Stocks To Own For 2019: CrossAmerica Partners LP(CAPL)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on CrossAmerica Partners (CAPL)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Ethan Ryder]

    CrossAmerica Partners (NYSE:CAPL) – Research analysts at Jefferies Group reduced their FY2018 earnings estimates for CrossAmerica Partners in a research note issued to investors on Wednesday, May 9th. Jefferies Group analyst C. Mandeville now forecasts that the oil and gas company will earn $0.24 per share for the year, down from their previous forecast of $0.32. Jefferies Group currently has a “Buy” rating and a $28.00 target price on the stock. Jefferies Group also issued estimates for CrossAmerica Partners’ Q1 2019 earnings at $0.07 EPS, Q2 2019 earnings at $0.13 EPS, Q4 2019 earnings at $0.14 EPS and FY2020 earnings at $0.42 EPS.

  • [By Monica Gerson]

    Crossamerica Partners LP (NYSE: CAPL) is projected to report its quarterly earnings at $0.05 per share on revenue of $479.03 million.

    Buckeye Partners, L.P. (NYSE: BPL) is expected to report its quarterly earnings at $1.04 per share on revenue of $1.00 billion.

Top Safest Stocks To Own For 2019: Sonic Automotive Inc.(SAH)

Advisors’ Opinion:

  • [By Lee Jackson]

    These companies also reported insider buying last week: Armour Residential REIT Inc. (NYSE: ARR), Ducommun Inc. (NYSE: DCO), PJT Partners Inc. (NYSE; PJT), Sonic Automotive Inc. (NYSE: SAH)and Tandy Leather Factory Inc. (NASDAQ: TLF).

Top Safest Stocks To Own For 2019: American Superconductor Corporation(AMSC)

Advisors’ Opinion:

  • [By Money Morning News Team]

    American Superconductor Corp.(Nasdaq: AMSC), based in Massachusetts, manufactures two-megawatt wind turbines and supplies for the construction of electrical power grids.

  • [By William Romov]

    According to S&P Capital IQ, shares of TTOO have an average price target of $5.75, representing 40.24% upside from current levels.

    Penny Stocks to Buy for December 2017, No. 4: American Superconductor Corp. (Nasdaq: AMSC)

    Massachusetts-based American Superconductor Corp. (Nasdaq: AMSC) makes two-megawatt wind turbines under the Windtec Solutions brand. The company also sells products and services to connect electricity-generating equipment with the power grid.

  • [By Lisa Levin] Gainers
    Marathon Patent Group Inc (NASDAQ: MARA) shares surged 30.2 percent to $5.01 after dropping 40.86 percent on Tuesday. Marathon Patent Group filed for sale of 1.85 million shares of common stock by selling stockholders.
    Capricor Therapeutics Inc (NASDAQ: CAPR) shares jumped 17.2 percent to $2.25 after the company reported the FDA clearance of Investigational New Drug application for CAP-1002.
    Rite Aid Corporation (NYSE: RAD) gained 13.2 percent to $2.15 following 16.5 percent rally on Tuesday.
    Photronics, Inc. (NASDAQ: PLAB) shares climbed 11.8 percent to $10.45 after the company reported stronger-than-expected earnings for its fourth quarter.
    China Distance Education Hldgs Ltd (ADR) (NYSE: DL) shares surged 11.3 percent to $8.67. China Distance Education reported Q4 profit of $5.9 million on revenue of $41.7 million.
    Cytokinetics, Inc. (NASDAQ: CYTK) shares gained 11 percent to $8.05 after falling 7.05 percent on Tuesday.
    Ooma Inc (NYSE: OOMA) shares surged 8.5 percent to $10.85 as the company posted strong Q3 results.
    Nuance Communications Inc. (NASDAQ: NUAN) climbed 8 percent to $17.12 after the company reported stronger-than-expected results for its fourth quarter on Tuesday.
    American Superconductor Corporation (NASDAQ: AMSC) surged 7.8 percent to $3.59 after the company reported $8 million in D-VAR system orders.
    Thermon Group Holdings Inc (NYSE: THR) rose 6.3 percent to $24.17. William Blair upgraded Thermon Group from Market Perform to Outperform.
    Domino's Pizza, Inc. (NYSE: DPZ) surged 6.1 percent to $182.88. Nomura upgraded Domino's from Neutral to Buy.
    Xencor Inc (NASDAQ: XNCR) rose 5.9 percent to $21.17. Cantor Fitzgerald initiated coverage on Xencor with an Overweight rating.
    Idera Pharmaceuticals Inc (NASDAQ: IDRA) gained 5.1 percent to $2.28 after the company disclosed that it has been granted FDA Fast Track designation for IMO-2125.
    Regal Entertainment Group (NYSE: RGC) gained 5.1 percent to

Top 5 Low Price Stocks To Own For 2018

Main thesis

I believe that Tuesday Morning (NASDAQ: TUES) is a potential turnaround situation with high upside and limited downside.

Business

According to their 10k,

We are a true closeout retailer, selling high-quality products at prices below those found in boutique, specialty and department stores. Our customers come to us for an ever-changing, exceptional assortment of brand names at great prices. Basically, they purchase items at a very low price from different sources and they sell it below retail.

What makes it interesting

Niche that is likely to be undisturbed by the ecommerce disruption right now Little debt ($30 million from accessing credit facility) with continued access to capital markets Increasing revenue despite industry headwinds, which means that the problem is likely to be internal. Insider buy in Concrete turnaround plan that could work (some of them are already working)

What I think the rest of the market missed

Only 1 analyst covering (according to yahoo finance) Niche presence in a market filled with big names Overall decrease in interest in the traditional brick and mortar retail sector Boring niche with little or no growth

Notable statistics

Top 5 Low Price Stocks To Own For 2018: Sonic Automotive Inc.(SAH)

Advisors’ Opinion:

  • [By Lee Jackson]

    These companies also reported insider buying last week: Armour Residential REIT Inc. (NYSE: ARR), Ducommun Inc. (NYSE: DCO), PJT Partners Inc. (NYSE; PJT), Sonic Automotive Inc. (NYSE: SAH)and Tandy Leather Factory Inc. (NASDAQ: TLF).

Top 5 Low Price Stocks To Own For 2018: Bayer Aktiengesellschaft (BAYZF)

Advisors’ Opinion:

  • [By SEEKINGALPHA.COM]

    For the third quarter, the company reported cash and equivalents of $470.4 million, while net income came in at $50 million (includes a gain of $78.7 million from the Immunomedics’ warrant). Without the one-time gain, its loss of $28.7 million would still be an improvement over net loss of $31.8 million for the same quarter last year. For the fourth quarter, the company is guiding for ADCETRIS sales in the range of $82 million to $84 million (total revenue of $128 million to $130 million). In addition to the growing opportunity for ADCETRIS (peak sales in excess of $1 billion) and the intriguing prospects of tucatinib, the company has a promising pipeline of ADC candidates and immuno-oncology assets. Partnered programs with the likes of AbbVie (NYSE:ABBV), Astellas (OTCPK:ALPMY), Genmab (OTCPK:GMXAY), Bayer (OTCPK:BAYZF), Genentech and many more also lend additional credibility to the story.

  • [By SEEKINGALPHA.COM]

    And this is pretty important ground. Hepatocellular carcinoma can be managed with local therapy (surgery, embolization, etc.), but at its most advanced stages, the options quickly start to thin out. For a decade, the only option in systemic therapy was Bayer’s (OTCPK:BAYZF) sorafenib. Recently, the effective systemic treatment armamentarium was doubled with the approval of regorafenib for second-line therapy.

  • [By SEEKINGALPHA.COM]

    Other R&D products in Regeneron’s pipeline that we are interested in

    Fasinumab: Antibody against nerve growth factor, being developed for pain treatment like osteoarthritis. It is partnered with Teva Pharmaceutical (NASDAQ:TEVA) (for osteoarthritis, in phase 3), and is also being developed for treatment of chronic back pain. It is licensed to Mitsubishi Tanabe for the Japan territory. REGN2222: For prevention of RSV virus infection in infants, competing with Synagis from AstraZeneca (NYSE:AZN). Nesvacumab: Angiopoetin 2 antibody, being tested in combination with Eylea (in phase 2, partnered with Bayer (OTCPK:BAYZF)). Rinucumab (anti-PDGF): Being tested in treatment of wet AMD in combination with Eylea. Phase 2 trial was not successful, but the treatment duration was less (only 12 weeks versus 24 weeks for rival Ophthotech (NASDAQ:OPHT)). 28-week and 52-week data will be released later. With Ophthotech’s phase 3 failure with Fovista, we are bullish on Rinucumab’s commercial potential in wet AMD. Immuno-oncology pipeline: Checkpoint inhibitors and novel CAR-T; still in early stage.

    Click to enlarge

  • [By SEEKINGALPHA.COM]

    Online Direct Sales – Once only consumer electronics and mobile handsets, the products it offers has grown to include 15 different categories, including home appliances and a wide array of general merchandise.

    In April, JD.com became a certified member of the American Apparel & Footwear Association (AAFA), the trusted public policy and political voice of the apparel and footwear industry, a first for a Chinese e-commerce company. In the first quarter of 2017, Avene, the leading demo-cosmetic brand for sensitive skin in European pharmacies, and three brands under Georgio Armani launched flagship stores on JD.com’s direct sales platform. JD Worldwide, a cross-border e-commerce platform set up in April 2015 to provide access to international brands (including those not available in China), has retail contracts with international brands such as Wal-Mart (NYSE:WMT), Phillips, Barcelona FC, and GNC (NYSE:GNC). Recently, it’s partnered with ASDA, a leading UK retailer under the Wal-Mart umbrella, as well as Bayer (OTCPK:BAYZF) and Cetaphil. As of March 2017, it operates 263 warehouses covering a gross floor area of 5.8 million square meters. GMV from the online direct sales business was RMB107.9 billion in the first quarter of 2017, up 42% from the first quarter of 2016. Net revenues from online direct sales increased by 40% in the first quarter of 2017 as compared to the first quarter of 2016. Fulfilled orders in the first quarter of 2017 were 477.1 million, an increase of 39% from 342.1 million in the same period in 2016. Fulfilled orders placed through mobile accounted for approximately 81% of total orders fulfilled in the first quarter of 2017, an increase of 56% compared to the same period in 2016.

    Online Marketplace – Third-party sellers offer products to customers and pay a commission to JD.com. They provide transaction processing and billing services on all orders on the online marketplace and leverage their own nationwide fulfillment infrastructu

  • [By SEEKINGALPHA.COM]

    We believe that the pharmaceutical sector has received too much negative attention. Despite the risks, a few companies offer good entry opportunities. In our previous article, we recommended Akorn. Today, we have analyzed Teva. We believe that the company is in a position to thrive in the generic market, and that it is priced very attractively. Yet, we don’t like management’s aggressive M&A strategy. We don’t like very aggressive companies since large acquisitions rarely create value for the shareholders. Contributors argue that Teva has overpaid for Actavis (its latest and largest acquisition) by at least $14B. This does not surprise us since most M&A deals are too expensive. Previous corruption issues add further doubts. Unfortunately, there is no amount of profit that can convince us to invest in a company where we do not like the management. We have sold our positions in Bayer (OTCPK:BAYZF) for similar reasons. We like Bayer, but we have sold our shares because of the Bayer-Monsanto (NYSE:MON) acquisition.

Top 5 Low Price Stocks To Own For 2018: Westinghouse Air Brake Technologies Corporation(WAB)

Advisors’ Opinion:

  • [By Lee Samaha]

    On a more positive note, Flannery appears to be making ground on some key long-term objectives.

    Management feels “good” about the ability of the healthcare segment to outperform, according to Miller. Flannery claimed GE was in “active discussions” on some aviation platforms, current & lighting and distributed power, while an announcement on the divestment of transportation (rumored to be a target of Wabtec (NYSE:WAB)) is expected by the end of the second quarter. Structural cost reductions are now expected to be above the $2 billion target outlined on the investor day presentation in November 2017. Flannery outlined that he would lead the creation of a new operating system for GE based on “lean, six sigma ad agile” involving “continuous improvement and customer experience.”

    As a reminder, GE has promised $20 billion of asset sales, and the commentary on the earnings call was reassuring, particularly as the first deal (healthcare IT assets) was underwhelming.

  • [By WWW.MONEYSHOW.COM]

    Westinghouse Air Brake Technologies Corporation (WAB) scores highly based on my Warren Buffett-based model, which is based on the book Buffettology, and also the Peter Lynch-inspired approach that uses the method outlined by Lynch in One Up on Wall Street.

  • [By Joseph Griffin]

    Mountain Pacific Investment Advisers Inc. ID cut its holdings in Wabtec Co. (NYSE:WAB) by 1.2% during the first quarter, HoldingsChannel.com reports. The firm owned 226,515 shares of the transportation company’s stock after selling 2,800 shares during the period. Wabtec comprises 1.9% of Mountain Pacific Investment Advisers Inc. ID’s investment portfolio, making the stock its 25th biggest position. Mountain Pacific Investment Advisers Inc. ID’s holdings in Wabtec were worth $18,438,000 at the end of the most recent quarter.

  • [By Matthew DiLallo]

    Westinghouse Air Brake Technologies(NYSE:WAB), or Wabtec, is off to a solid start in 2018. The rail products company reported double-digit gains in revenue and earnings thanks to a combination of factors. As a result, the company remains on pace to hit its full-year guidance.

Top 5 Low Price Stocks To Own For 2018: Antares Pharma, Inc.(ATRS)

Advisors’ Opinion:

  • [By Lisa Levin]

    In trading on Friday, healthcare shares fell 0.32 percent. Meanwhile, top losers in the sector included Antares Pharma Inc (NASDAQ: ATRS), down 38 percent, and Infinity Pharmaceuticals Inc. (NASDAQ: INFI) down 16 percent.

  • [By Logan Wallace]

    BidaskClub upgraded shares of Antares Pharma (NASDAQ:ATRS) from a buy rating to a strong-buy rating in a research note issued to investors on Tuesday morning.

Top 5 Low Price Stocks To Own For 2018: Orexigen Therapeutics, Inc.(OREX)

Advisors’ Opinion:

  • [By Paul Ausick]

    Orexigen Therapeutics Inc. (NASDAQ: OREX) traded down about 12% Tuesday and posted a new 52-week low of $0.29 after closing Monday at $0.33. The stock’s 52-week high is $4.46. Volume was around 5.9 million, about 8 times the daily average. The company filed Monday for Chapter 11 bankruptcy.

  • [By Paul Ausick]

    Orexigen Therapeutics Inc. (NASDAQ: OREX) traded down about 78% Monday and posted a new 52-week low of $0.31 after closing Friday at $1.40. The stock’s 52-week high is $4.46. Volume was around 7.5million, about 15 times the daily average. The company has filed for Chapter 11 bankruptcy.

  • [By Cameron Saucier]

    Orexigen Therapeutics (Nasdaq: OREX) is a biopharmaceutical company that aims to treat obesity. The company’s flagship drug, Contrave, is approved by the Food and Drug Administration (FDA) in the United States. The drug regulates appetite, energy use, and the central nervous system. OREX rose 63% last month after it announced a new commercial and distribution agreement with Biologix FZCO. The agreement will cover 10 countries in the Middle East. OREX is currently trading at $3.30 per share and is down 79% as of Jan. 9 year over year (YOY).

  • [By Peter Graham]

    A long term chart shows Arena Pharmaceuticals along with its small capobesitytreatmentpeers EnteroMedics Inc (NASDAQ: ETRM), Orexigen Therapeutics, Inc (NASDAQ: OREX) and VIVUS, Inc (NASDAQ: VVUS) all causing severe weight loss for investor portfolios:

  • [By Keith Speights]

    Arena is out of the obesity drug business, but what about Orexigen Therapeutics (NASDAQ:OREX) or VIVUS (NASDAQ:VVUS)? The problem is that they’re both too dependent on their respective obesity drugs, Contrave and Qsymia. Neither of the drugs have performed up to expectations.

Hot Value Stocks To Own Right Now

Medidata’s architecture, reporting and analytics – a straightforward growth strategy

Most investors including myself are constantly looking at screens for new ideas. It may be that there have been fewer IPOs lately than the historical norm, but that does not mean that there aren’t plenty of IT names, far beyond the abilities of my brain to encompass, that are worth a look.

A very useful tool for screening that I have found recently comes from the team that covers the IT space at Credit Suisse (NYSE:CS). CS has a team that exclusively covers SaaS software vendors. The team has developed a tool based on linear regression that portrays a method of valuing the companies in their universe. The results of their work is a graphic that plots what they describe as the unit economics of 37 different vendors who sell their software on a subscription basis. The graphic illustrates a plot of the unit economics, i.e. the customer lifetime value/customer acquisition costs as defined by the analysts against their EV/S ratios as forecast for the next 12 months. It sounds far more complicated than is really the case. I like the tool developed by the analysts as providing some kind of reality check in terms of looking at a wide variety of software vendors addressing different markets. It is a tool that relates to both growth and efficiency, one of the most difficult analytical conundrums with which to deal. It replaces the conventions of accounting that do not properly account for the economics of the new software world and which lead many observers and commentators into a land of pointless nay saying that leads to conclusions that ultimately do not work out.

Hot Value Stocks To Own Right Now: SteadyMed Ltd.(STDY)

Advisors’ Opinion:

  • [By Lisa Levin]

    Gainers

    Pyxis Tankers Inc. (NYSE: PXS) rose 47.48 percent to $$5.56, after the company announced it has entered into a definitive securities purchase agreement with a group of investors, which will result in gross proceeds of $4.8 million.
    Sigma Designs Inc (NASDAQ: SIGM) rose 22.77 percent to $6.88. Silicon Laboratories (NASDAQ: SLAB) announced plans to buy Sigma Designs for $7.05 per share in cash.
    Steadymed Ltd (NASDAQ: STDY) rose 19.35 percent to $3.70, after the company reported that no clinical trials were required for Trevyent and that the FDA had agreed to the pathway for the drug candidate's NDA resubmission.
    Iteris, Inc. (NASDAQ: ITI) rose 15.73 percent to $7.06. Earlier in the week, Zacks Investment Research had upgraded the company from "Sell" to "Hold".
    Science Applications International Corp (NYSE: SAIC) rose 13.71 percent to $85.77 as the company reported better-than-expected earnings for its third quarter.
    Technical Communications Corporation (NASDAQ: TCCO) rose 12.41 percent to $6.07, after having risen sharply in pre-marketing trading.
    Radius Health, Inc. (NASDAQ: RDUS) rose 12.41 percent to $30.81 after the company provided an update on data from the Phase 1 005 clinical study of elacestrant in patients with estrogen receptor positive breast cancer during the 2017 San Antonio Breast Cancer Symposium.
    ForeScout Technologies, Inc. (NASDAQ: FSCT) rose 12.32 percent to $25.80 after the company reported its third quarter financial results.
    Prana Biotechnology Limited (NASDAQ: PRAN) rose 11.36 percent to $3.43, as the company announced a research collaboration with Takeda Pharmaceuticals to study the ability of movement disorders compound, PBT434 to slow or prevent neurodegeneration of the gastrointestinal system.
    Catalyst Biosciences, Inc. (NASDAQ: CBIO) rose 10.49 percent to $7.90 as the company announced the appointment of Arwa Shurrab and Jamie Ellen Siegel in its clinical hemophilia

Hot Value Stocks To Own Right Now: Sonic Automotive Inc.(SAH)

Advisors’ Opinion:

  • [By Lee Jackson]

    These companies also reported insider buying last week: Armour Residential REIT Inc. (NYSE: ARR), Ducommun Inc. (NYSE: DCO), PJT Partners Inc. (NYSE; PJT), Sonic Automotive Inc. (NYSE: SAH)and Tandy Leather Factory Inc. (NASDAQ: TLF).

Hot Value Stocks To Own Right Now: Jazz Pharmaceuticals Inc.(JAZZ)

Advisors’ Opinion:

  • [By Lisa Levin] Gainers
    Trevena Inc (NASDAQ: TRVN) rose 10.8 percent to $3.60 in pre-market trading after dropping 4.97 percent on Wednesday.
    Yum China Holdings Inc (NYSE: YUMC) rose 10.2 percent to $31.05 in pre-market trading after the company reported upbeat earnings for its first quarter.
    Seres Therapeutics Inc (NASDAQ: MCRB) rose 9.1 percent to $11.39 in pre-market trading after dropping 5.26 percent on Wednesday.
    Plug Power Inc (NASDAQ: PLUG) rose 8.9 percent to $2.45 in pre-market trading after surging 73.08 percent on Wednesday.
    Coach Inc (NYSE: COH) rose 6.7 percent to $41.98 in pre-market trading. Coach named Ian Bickley as President, Global Business Development and Strategic Alliances.
    Sapiens International Corporation N.V. (NASDAQ: SPNS) shares rose 6.1 percent to $13.91 in pre-market trading after gaining 0.54 percent on Wednesday.
    Jazz Pharmaceuticals plc (NASDAQ: JAZZ) rose 6.1 percent to $149.15 in pre-market trading. Jazz Pharma reached a settlement with Hikma Pharma related to Xyrem patent case. Mizuho downgraded Jazz from Buy to Neutral.
    Interactive Brokers Group, Inc. (NASDAQ: IBKR) shares rose 6 percent to $36.72 in pre-market trading after declining 0.03 percent on Wednesday.
    Rewalk Robotics Ltd (NASDAQ: RWLK) rose 5.3 percent to $2.00 in pre-market trading after the company disclosed that the U.S. Department of Veterans Affairs purchased 28 added Exoskeleton Systems.
    Merrimack Pharmaceuticals Inc (NASDAQ: MACK) rose 5.1 percent to $3.29 in pre-market trading. Merrimack declared a $1.06 special dividend.
    BioTime, Inc. (NYSE: BTX) shares rose 4.8 percent to $3.50 in pre-market trading. BioTime, reported the formation of new subsidiary AgeX Therapeutics, Inc.
    Akari Therapeutics PLC (ADR) (NASDAQ: AKTX) shares rose 4.8 percent to $12.26 in pre-market trading after gaining 0.69 percent on Wednesday.
    Bed Bath & Beyond Inc. (NASDAQ: BBBY) rose 3.6 percent to $39.15 in pre-market trading after the company posted better-than
  • [By Jim Robertson]

    The earnings report summarized the following recent milestones:

    The formation of a Scientific Advisory Board (SAB) to provide expert guidance and insight as the Company advances towards product commercialization. in October, Pfenex announced the hiring of Steven Sandoval as Chief Manufacturing Officer.Steven has over 25 years of commercial biopharmaceutical engineering and operations experience, specializing in commercial operations, facility design and licensure of large scale biopharmaceutical commercial manufacturing facilities. Following the announcement in August of the positive Phase 1 trial data for Pfenex’s recombinant anthrax vaccine, discussions with BARDA have been progressing. Pfenex anticipates initiating the PF708 pivotal clinical program by year end. Pfenex entered into a collaboration with Jazz Pharmaceuticals plc (NASDAQ: JAZZ) on multiple hematology/oncology product candidates in July. Regulatory feedback for PF529, Pfenex’s biosimilar candidate to Neulasta (pegfilgrastim), is expected by the end of 2016 and following that feedback, the development path and potential timeline will be outlined.

    Do you like this trading idea and want more trading setups delivered to you every day? Consider investing in a subscription to our SmallCap Network Elite Opportunity (SCN EO) portfolio newsletter or our Under the Radar Movers newsletter where you’ll get more and even better trading setups, investing ideas or tips.

  • [By Keith Speights]

    In December, I included Jazz Pharmaceuticals (NASDAQ:JAZZ) in a list of the three top healthcare stocks investors were overlooking. At that time, I noted that the biotech stock could be a diamond in the rough with its promising pipeline and low valuation.

Hot Value Stocks To Own Right Now: The Hackett Group Inc.(HCKT)

Advisors’ Opinion:

  • [By Lisa Levin]

    In trading on Wednesday, industrial shares were relative laggards, down on the day by about 0.20 percent. Meanwhile, top losers in the sector included The Hackett Group, Inc. (NASDAQ: HCKT), down 22 percent, and PC Tel Inc (NASDAQ: PCTI), down 18 percent.

Hot Value Stocks To Own Right Now: M&T Bank Corporation(MTB)

Advisors’ Opinion:

  • [By Ben Levisohn]

    We believe investors should continue to own three types of bank stocks: “Return of Capital (RC) Stocks”, “Risk On (RO) Stocks”, and “Multiple Revaluation (MR) Stocks.” RC stocks include M&T Bank (MTB), PNC Financial Services Group (PNC), and SunTrust Banks (STI); RO stocks include Bank of America, Popular (BPOP), Citigroup, JPMorgan, and KeyCorp (KEY); and MR stocks include BB&T (BBT) and PNC Financial Services Group (PNC).

Top Heal Care Stocks To Own For 2018

Although they got off to a slow start despite Monday morning’s news that January’s durable goods orders were up 1.8%, it didn’t take long for the bulls to find their footing. The S&P 500 gained another 0.10% today, ending the session at 2,369.73. It and the Dow Jones Industrial Average both hit record highs, and both finished the session at record high closes.

It wasn’t a banner day for all stocks though. Just ask owners of AmTrust Financial Services Inc (NASDAQ:AFSI), ServiceNow Inc (NYSE:NOW) and Tesla Inc (NASDAQ:TSLA).

Here’s what went wrong for each one.

Tesla Inc (TSLA)

For the second time in three days, electric vehicle maker and (now) solar power player Tesla has earned a spot on the daily ‘Worst 3’ list; today’s setback was ultimately rooted in the same reason TSLA stock tumbled so much on Thursday of last week.

Top Heal Care Stocks To Own For 2018: CNH Industrial N.V.(CNHI)

Advisors’ Opinion:

  • [By Ben Levisohn]

    I wrote bullishly about Deere (DE) back in December, and since then the stock has done…not much, gaining 4.8% to the S&P 500′s 4.1% rise. So I’ve tried to stay on top of the stock, both the bullish calls and the bearish ones–and today, I have another bear to add to the list. That would be JPMorgan’s Ann Duignan, who reiterated her Underweight rating on Deere today, as well as CNH Industrial (CNHI) and Agco (AGCO). She explains why:

Top Heal Care Stocks To Own For 2018: Sonic Automotive Inc.(SAH)

Advisors’ Opinion:

  • [By Lee Jackson]

    These companies also reported insider buying last week: Armour Residential REIT Inc. (NYSE: ARR), Ducommun Inc. (NYSE: DCO), PJT Partners Inc. (NYSE; PJT), Sonic Automotive Inc. (NYSE: SAH)and Tandy Leather Factory Inc. (NASDAQ: TLF).

Top Heal Care Stocks To Own For 2018: Roper Technologies, Inc.(ROP)

Advisors’ Opinion:

  • [By Shane Hupp]

    Roper Technologies (NYSE: ROP) and Danaher (NYSE:DHR) are both large-cap industrial products companies, but which is the better business? We will compare the two businesses based on the strength of their profitability, dividends, institutional ownership, earnings, valuation, risk and analyst recommendations.

  • [By Garrett Baldwin]

    Shares of General Electric Co. (NYSE: GE) are in focus after the company reported earnings before the bell. GE stock popped 5.6% after the firm topped earnings per share (EPS) estimates by $0.05 and backed its 2018 outlook. The firm reported EPS of $0.16 on top of $28.66 billion in revenue. GE stock had been off nearly 18% from its last earnings report on January 24 due to ongoing financial and legal problems.
    Crude oil prices dipped Friday after U.S. President Donald Trump took aim at OPEC. Trump accused the cartel of keeping oil prices “artificially high” despite “record amounts of oil all over the place.” Brent crude and WTI crude oil both hit three-year highs this week after Saudi Arabia suggested that it was working to press oil prices back above $100 per barrel.
    Three Stocks to Watch Today: PM, MO, WFC
    Shares of Philip Morris International Inc.(NYSE: PM) fell this morning after the firm experienced its worst trading day since its spin-off from Altria Group Inc. (NYSE: MO). Shares of PM fell as much as 16% after the firm fell short of revenue expectations after the bell. MO stock fell roughly 6% on the day.
    Shares of Wells Fargo & Co. (NYSE: WFC) are under pressure after The New York Times reported that the firm may be facing a $1 billion fine. The fines would cover a variety of “alleged” misdeeds that include the firm’s push on customers to purchase auto insurance they didn’t need and charging mortgage customers fees for services that they were not using. The Consumer Financial Protection Bureau and the Office of the Comptroller of the Currency will most likely announce the fine today. Money MorningCapital Wave StrategistShah Gilani weighed in on the topic this week, and he offers a scorching indictment.
    Qualcomm Inc. (Nasdaq: QCOM) is on the move today after the semiconductor giant announced plans to lay off 1,500 employees. The cuts are expected to hit employees in California and cities around the globe. The cuts are part of the fi

  • [By Monica Gerson]

    Roper Technologies Inc (NYSE: ROP) is projected to report its quarterly earnings at $1.46 per share on revenue of $895.87 million.

    Express Scripts Holding Company (NASDAQ: ESRX) is expected to post its quarterly earnings at $1.22 per share on revenue of $25.20 billion.

  • [By Monica Gerson]

    Analysts are expecting Roper Technologies Inc (NYSE: ROP) to have earned $1.46 per share on revenue of $895.87 million in the latest quarter. Roper Technologies shares declined 0.05 percent to close at $178.63 on Friday.

Top Heal Care Stocks To Own For 2018: Pentair plc.(PNR)

Advisors’ Opinion:

  • [By Ben Levisohn]

    While the direct revenue exposure to the UK is relatively small across our coverage (aside fromTyco and Idex), the potential impact from Brexit is much more widespread across the continent and the world. The impact should be most negative for our companies with larger industrial exposure to Europe, just as we have begun to hear incrementally positive commentary regarding Europe.Idex andTyco have some of the highest direct exposures to UK and Europe but Tyco’s business should be relatively more stable and in any case theJohnson Controls (JCI) synergies loom large. Eaton (ETN) and Emerson Electric, though with slightly smaller exposure, are more involved with industrial spending.Danaher andHoneywell have high revenue exposure, but we believe that their more benign end market exposure should mitigate some of the negative consequences they face. We rate Allegion (ALLE), Danaher, Dover (DOV), Fortive (FTV), Honeywell, Ingersoll-Rand (IR), Pentair (PNR) andTyco Outperform; Emerson Electric, Eaton, General Electric (GE),Idex and 3M (MMM) Market-Perform; Rockwell Automation (ROK) Underperform.

  • [By Ben Levisohn]

    RBC’s Deane Dray and team worry that valuations of industrial stocks like General Electric (GE), Danaher (DHR), Honeywell International (HON), Ingersoll-Rand (IR) and Pentair (PNR) have gotten ahead of themselves and recommend a “barbell strategy” when playing the sector. They explain:

  • [By Garrett Baldwin]

    WTI crude oil prices added 1.2% to hit $69.31 per barrel, while Brent crude added 1.4% to hit $74.50. The uptick came after Saudi Arabia hinted that it would like to see oil prices hit the top end of the $80 to $100 range. The key oil supplier has been working with other OPEC producers and Russia to support crude prices to reduce excessive global production. The nations’ agreement is expected to extend well into 2019 and potentially beyond that time frame.
    This morning, as it topped earnings expectations, Procter & Gamble Co. (NYSE: PG) announced it will purchase the consumer health business of German pharma giant Merck KGaA (OTCMKTS: MKGAF) for nearly $4.2 billion. The deal will expand on P&G’s vitamins and health supplement business. This is the first deal made by P&G since activist investor Nelson Peltz won a board seat last year.
    Four Stocks to Watch Today: PM, AXP, AMZN, COST
    Shares of Phillip Morris International Inc.(NYSE: PM) dropped 3.6% in pre-market hours after the company fell short of revenue expectations. Despite reporting earnings per share (EPS) of $1.00, a figure that topped estimates by $0.12, the firm fell short of the $7.02 billion in revenue forecasted by analysts.
    American Express Co.(NYSE: AXP) popped nearly 4% after the company easily topped Wall Street earnings after the bell Wednesday. The firm’s strategy to spend $2.35 billion on customer rewards promotions wooed a large amount of accounts and upgrades during the first three months of 2018. AXP reported EPS of $1.86 on top of $9.72 billion in revenue. Wall Street forecasted $1.71 per share on $9.20 billion.
    Amazon.com Inc.(Nasdaq: AMZN) is in focus after two stunning revelations emerged from the company on Wednesday. CEO Jeff Bezos announced that the company has more subscribers to its Prime service than Costco Corp.(Nasdaq: COST), while the average Amazon employee earned under $30,000 in 2017.
    Look for additional earnings reports from Skechers USA In

  • [By Lee Jackson]

    Pentair PLC(NYSE: PNR) had a major holder and director of the company buying more shares last week. Trian Fund purchased 863,000 shares of this diversified industrial manufacturing company at prices that ranged from $65.13 to $65.41 apiece. The total for the trade was posted at a huge $56 million. The stock closed Friday at $67.11, so the purchase appears to be well timed. The52-week trading range is $53.80 to $69.03, and the Wall Street consensus price objective is $67.50.

  • [By William Patalon III]

    Water-equipment company – and Private Briefing favorite – Pentair PLC (NYSE: PNR) left investors with mixed feelings after reported its earnings on Tuesday.